Somatostatin therapy of acute experimental pancreatitis.
Open Access
- 1 September 1977
- Vol. 18 (9) , 713-716
- https://doi.org/10.1136/gut.18.9.713
Abstract
Because somatostatin (SRIF) reduces exocrine pancreatic secretion, its effect on acute pancreatitis was investigated in rats. Linear SRIF reduced serum amylase and lipase but had no effect on pancreatic necrosis, oedema, leucocyte infiltration, and enzyme content. The mortality rate was not reduced. These results do not recommend the use of SRIF in the treatment of acute pancreatitis.This publication has 17 references indexed in Scilit:
- The preparation and properties of two new chromogenic substrates of trypsinPublished by Elsevier ,2004
- Effects of Somatostatin on Exocrine and Endocrine Pancreatic Function Stimulated by Intestinal Hormones in ManHormone and Metabolic Research, 1976
- Somatostatin Suppresses Secretin and Pancreatic Exocrine SecretionScience, 1975
- [Inhibition by somatostatin of pancreatic juice and enzyme secretion and gallbladder contraction in man induced by secretin and cholecystokinin-pancreozymin administration (author's transl)].1975
- The Influence of Glucagon on Acute Experimental Pancreatitis in the RatScandinavian Journal of Gastroenterology, 1974
- Experimental Pancreatitis Treated With Glucagon or Lactated Ringer SolutionArchives of Surgery, 1974
- Testing Pancreatic FunctionNew England Journal of Medicine, 1972
- Use of Glucagon in the Treatment of PancreatitisBMJ, 1971
- An ultra-micro method for determination of amyease activity in blood serumClinica Chimica Acta; International Journal of Clinical Chemistry, 1958
- Determination ok amylase activity in biological fluidsClinica Chimica Acta; International Journal of Clinical Chemistry, 1956